WEST, JOE, STILWELL, PETER, LIU, HANHUA, BAN, LU, BYTHELL, MARY, CARD, TIM R, LANYON, PETER, NANDURI, VASANTA, RANKIN, JUDITH, BISHTON, MARK J and CROOKS, COLIN J, 2022. Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003-2018. HemaSphere. 6(11), e797
AL-HAKIM, ADAM, POULTER, JAMES A., MAHMOUD, DINA, ROSE, AILSA M. S., ELCOMBE, SUZANNE, LACHMANN, HELEN, CARGO, CATHERINE, DUNCAN, CHRISTOPHER J. A., BISHTON, MARK, BIGLEY, VENETIA, KHAN, ANJUM and SAVIC, SINISA, 2022. Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience BRITISH JOURNAL OF HAEMATOLOGY. 199(5), 777-781
LIU, HANHUA, STILLER, CHARLES A., CROOKS, COLIN J., ROUS, BRIAN, BYTHELL, MARY, BROGGIO, JOHN, RANKIN, JUDITH, NANDURI, VASANTA, LANYON, PETER, CARD, TIM R., BAN, LU, ELLISS-BROOKES, LUCY, BROUGHAN, JENNIFER M., PALEY, LIZZ, WONG, KWOK, BACON, ANDREW, BISHTON, MARK and WEST, JOE, 2022. Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013-2019 BRITISH JOURNAL OF HAEMATOLOGY. 199(5), 728-738
NASTOUPIL, LORETTA J., MORSCHHAUSER, FRANCK, SCHOLZ, CHRISTIAN W., BISHTON, MARK, YOON, SUNG-SOO, GIRI, PRATYUSH, WEI, MICHAEL C., KNAPP, ANDREA, LI, CHI-CHUNG, BOTTOS, ALESSIA, LI, HAOCHENG, PUREV, ENKHTSETSEG and BARTLETT, NANCY L., 2022. CELESTIMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab plus lenalidomide versus rituximab plus lenalidomide in patients with relapsed or refractory follicular lymphoma who have received >= 1 line of systemic therapy. JOURNAL OF CLINICAL ONCOLOGY. 40(16),
CHANDRASHEKAR, RASHMI, MARTINEZ-CALLE, NICOLAS, AL SHALABI, MUFID, MCMILLAN, ANDREW, RICHARDSON, FAITH, ADLINGTON, JOANNE, ELLISON, LOUISE, FOX, CHRISTOPHER P. and BISHTON, MARK, 2022. Bisphosphonate prophylaxis in Lymphoma patients treated with steroid containing regimens BRITISH JOURNAL OF HAEMATOLOGY. 197, 111-111
MORSCHHAUSER, FRANCK, BISHTON, MARK, EYRE, TOBY A., BACHY, EMMANUEL, CARTRON, GUILLAUME, YSEBAERT, LOIC, BOBILLO, SABELA, GUTIERREZ, NORMA C., BUDDE, ELIZABETH, FOX, CHRISTOPHER P., KNAPP, ANDREA, YAQUB, MANEJEH, WEI, MICHAEL C., O'HEAR, CAROL, LI, HAOCHENG, PUREV, ENKHTSETSEG and TOWNSEND, WILLIAM, 2022. Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study BRITISH JOURNAL OF HAEMATOLOGY. 197, 105-106
BISHTON, MARK, MARSHALL, SCOTT, HARCHOWAL, JATINDER, SALLES, GILLES, GOLFIER, CAMILLE, TUCCI, ALESSANDRA, FERNANDEZ, ALICIA RODRIGUEZ, BLANCO, JOSE JAVIER SANCHEZ, BOCCHIA, MONICA, KIM, SOOKYOUNG, LEE, YOUNG NAM and ZINZANI, PIER LUIGI, 2022. The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe HEMATOLOGICAL ONCOLOGY. 40(3), 370-380
WEST, JOE, CARD, TIM R., BISHTON, MARK J., LANYON, PETER, BAN, LU, BYTHELL, MARY, ELLISS-BROOKES, LUCY, MANSON, JESSICA J., NANDURI, VASANTA, RANKIN, JUDITH, TATTERSALL, RACHEL S. and CROOKS, COLIN J., 2022. Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from England JOURNAL OF INTERNAL MEDICINE. 291(4), 493-504
LEWIS, KATHARINE LOUISE, JAKOBSEN, LASSE H., VILLA, DIEGO, BOBILLO, SABELA, SMEDBY, KARIN EKSTROEM, SAVAGE, KERRY J., EYRE, TOBY A., CWYNARSKI, KATE, CAPORN, PARIS L., VAN ZYL, JOAN, KLANOVA, MAGDALENA, TRNENY, MAREK, PUCKRIN, ROBERT, STEWART, DOUGLAS A., BISHTON, MARK J., FOX, CHRISTOPHER P., TUN, AUNG M., THANARAJASINGAM, GITA, DJEBBARI, FAOUZI, JOFFE, EREL, ELORANTA, SANDRA, HARRYSSON, SARA, SEHN, LAURIE H., MALISKE, SETH M., POONSOMBUDLERT, KITTIKA, GUO, XIAO, HAPGOOD, GREG, MANOS, KATE, HAWKES, ELIZA, KHWAJA, JAHANZAIB, MINSON, ADRIAN, DICKINSON, MICHAEL, OVLISEN, ANDREAS KIESBYE, GREGORY, GARETH P., GILBERTSON, MICHAEL, STREIT, ISAAC T., SCOTT, HAMISH W., KU, MATTHEW, DE MEL, SANJAY, YONG, KAR YING, XIN, LIU, MOKOONLALL, MRIDULA, TALAULIKAR, DIPTI, MCVILLY, NICHOLAS L., JOHNSTON, ANNA, BRUNNER, MATTHEW J., POPHALI, PRIYANKA A., MAURER, MATTHEW J., EL-GALALY, TAREC CHRISTOFFER and CHEAH, CHAN YOON, 2021. High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients BLOOD. 138,
WANG, MICHAEL, RAMCHANDREN, RADHAKRISHNAN, CHEN, ROBERT, KARLIN, LIONEL, CHONG, GEOFFREY, JURCZAK, WOJCIECH, WU, KA LUNG, BISHTON, MARK, COLLINS, GRAHAM P., ELIADIS, PAUL, PEYRADE, FREDERIC, LEE, YIHUA, ECKERT, KARL, NEUENBURG, JUTTA K. and TAM, CONSTANTINE S., 2021. Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study JOURNAL OF HEMATOLOGY & ONCOLOGY. 14(1),
BISHTON, MARK J., STILWELL, PETER, CARD, TIM R., LANYON, PETER, BAN, LU, ELLISS-BROOKES, LUCY, MANSON, JESSICA, NANDURI, VASANTA, EARP, KATE, FLOWER, LUKE, AMARNANI, RAJ, RANKIN, JUDITH, SEN, ETHAN S., TATTERSALL, RACHEL S., CROOKS, COLIN J., ASTON, JEANETTE, SISKOVA, VERONIKA, WEST, JOE and BYTHELL, MARY, 2021. A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population-based health data BRITISH JOURNAL OF HAEMATOLOGY. 194(6), 1039-1044
KAJI, FURQAAN A., MARTINEZ-CALLE, NICOLAS, BISHTON, MARK J., FIGUEROA, ROCIO, ADLINGTON, JOANNE, O'DONOGHUE, MICHAEL, SMITH, STUART, BYRNE, PAUL, PAINE, SIMON, SOVANI, VISHAKHA, AUER, DOROTHEE, JAMES, ELEANOR, BESSELL, ERIC M., GRAINGE, MATTHEW J. and FOX, CHRISTOPHER P., 2021. Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom BRITISH JOURNAL OF HAEMATOLOGY. 195(4), 561-570
GLOVER, ALEXANDER, MARTINEZ-CALLE, NICOLAS, FOX, CHRISTOPHER, BISHTON, MARK, BYRNE, JENNY, RUSSELL, NIGEL and RADIA, ROHINI, 2021. Long Term Outcomes of Allogeneic Transplantation In Lymphoma: A Single Centre Experience BONE MARROW TRANSPLANTATION. 56(SUPPL 1), 124-126
MARTINEZ-CALLE, NICOLAS, KIRKWOOD, AMY A., LAMB, MAXINE, SMITH, ALEX, KHWAJA, JAHANZAIB, MANOS, KATE, SHRUBSOLE, CAROLINE, GRAY, NICOLA, LEWIS, KATHARINE, TIVEY, ANN, BISHTON, MARK J., HAWKES, ELIZA, AHEARNE, MATTHEW J., OSBORNE, WENDY, COLLINS, GRAHAM P., ILLIDGE, TIMOTHY, LINTON, KIM M., CWYNARSKI, KATE, BURTON, CATHY and FOX, CHRISTOPHER P., 2021. Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort ADVANCES IN THERAPY. 38(7), 3789-3802
HALLIGAN, SARAH, GRAINGE, MATTHEW J., MARTINEZ-CALLE, NICOLAS, FOX, CHRISTOPHER P. and BISHTON, MARK, 2021. Population-based cohort study of the efficacy of Brentuximab-Vedotin in relapsed systemic Anaplastic Large Cell Lymphoma using Public Health England data BRITISH JOURNAL OF HAEMATOLOGY. 193, 153-154
RAMPOTAS, ALEXANDROS, WILSON, MATTHEW R., LOMAS, OLIVER, DENNY, NICHOLAS, LEARY, HEATHER, FERGUSON, GRAEME, MCKAY, PAMELA, EBSWORTH, TIM, MILLER, JONATHAN, SHAH, NIMISH, MARTINEZ-CALLE, NICOLAS, BISHTON, MARK, EVERDEN, ANGHARAD, TUCKER, DAVID, EL-HASSAD, EZZAT, HENNESSY, BRIAN, DOHERTY, DEARBHLA, PRIDEAUX, STEVE, FARYAL, REHMAN, HAYAT, AMJAD, KEOHANE, CLODAGH, MARR, HELEN, GIBB, ADAM, POCOCK, RACHAEL, LAMBERT, JONATHAN, LACEY, RACHEL, ELMUSHARAF, NAGAH, CLIFFORD, RUTH and EYRE, TOBY A., 2021. Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis BRITISH JOURNAL OF HAEMATOLOGY. 194(2), 365-377
EYRE, TOBY A., WILSON, WILLIAM, KIRKWOOD, AMY A., WOLF, JULIA, HILDYARD, CATHERINE, PLASCHKES, HANNAH, GRIFFITH, JOHN, FIELDS, PAUL, GUNAWAN, ARIEF, OLIVER, REBECCA, BOOTH, STEPHEN, KOTHARI, JAIMAL, FOX, CHRISTOPHER P., MARTINEZ-CALLE, NICOLAS, MCMILLAN, ANDREW, BISHTON, MARK, COLLINS, GRAHAM P. and HATTON, CHRIS S. R., 2021. Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP BLOOD ADVANCES. 5(8), 2229-2236
BARRACLOUGH, ALLISON, BISHTON, MARK, CHEAH, CHAN Y., VILLA, DIEGO and HAWKES, ELIZA A., 2021. The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma BRITISH JOURNAL OF HAEMATOLOGY. 195(1), 15-24
MCCULLOCH, RORY, LEWIS, DAVID, CROSBIE, NICOLA, EYRE, TOBY A., BOLAM, SIMON, ARASARETNAM, ANITA, CREASEY, THOMAS, GORADIA, HARSHITA, MCMILLAN, ANNABEL, DAWI, SAFIA, HARRISON, SAMUEL, MILES, OLIVER, ROBINSON, ANDREW, DUTTON, DAVID, WILSON, MATTHEW R., MCKAY, PAM, FOLLOWS, GEORGE, PHILLIPS, NEIL, PATMORE, RUSSELL, LAMBERT, JONATHAN, BISHTON, MARK, OSBORNE, WENDY, JOHNSTON, ROSALYND, KIRKWOOD, AMY A. and RULE, SIMON, 2021. Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients BRITISH JOURNAL OF HAEMATOLOGY. 193(2), 290-298
GAIOLLA, RAFAEL, HARTLEY, SARAH, BEECH, AMY, KNIGHT, HELEN, SMITH, DEAN, BISHTON, MARK, FOX, CHRISTOPHER P. and MARTINEZ-CALLE, NICOLAS, 2021. Extended follow-up of CD4(+) T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine HEMATOLOGICAL ONCOLOGY. 39(1), 137-140
TAM, CONSTANTINE S., RAMCHANDREN, RADHAKRISHNAN, CHEN, ROBERT, KARLIN, LIONEL, CHONG, GEOFFREY, JURCZAK, WOJCIECH, WU, KA LUNG, BISHTON, MARK, COLLINS, GRAHAM P., ELIADIS, PAUL, PEYRADE, FREDERIC, SZAFER-GLUSMAN, EDITH, LEE, YIHUA, ECKERT, KARL, NEUENBURG, JUTTA K. and WANG, MICHAEL, 2020. Ibrutinib Plus Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Results From the Safety Run-In Period of the Phase 3 Sympatico Study BLOOD. 136,
ARULOGUN, SUZANNE O., BRIAN, DUNCAN, GORADIA, HARSHITA, COONEY, AARON, MENNE, TOBIAS, TALAULIKAR, DIPTI, O'NEILL, AIDEEN THERESE, VOS, JOSEPHINE M. I., PRATT, GUY, TURNER, DEBORAH, MARSHALL, KIRSTY, MANOS, KATE, ANDERSON, CLAIRE, GAVRIATOPOULOU, MARIA, KYRIAKOU, CHARALAMPIA, MINNEMA, MONIQUE C., EL-SHARKAWI, DIMA, KERSTEN, MARIE JOSE, KOO, RAYMUN, MCCARTHY, HELEN, BISHTON, MARK, FOLLOWS, GEORGE, WECHALEKAR, ASHUTOSH D. and D'SA, SHIRLEY, 2020. Bendamustine Plus Rituximab for the Treatment of Waldenstrom Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing BLOOD. 136,
GLOVER, ALEXANDER, FOX, CHRISTOPHER P., MCMILLAN, ANDREW, BEECH, AMY, MARTINEZ-CALLE, NICHOLAS, GRIFFITHS, CATHERINE, RICHARDSON, FAITH, RUSSELL, NIGEL and BISTON, MARK J., 2020. A comparison of bendamustine-EAM versus BEAM conditioning for autogolous stem cell transplant in lymphoma LEUKEMIA & LYMPHOMA. 61(14), 3529-3531
MCCULLOCH, R., RULE, S., EYRE, T., BOLAM, S., CREASEY, T., DUTTON, D., DAWI, S., WILSON, M., MILES, O., HARRISON, S., GORADIA, H., MCMILLAN, A., MCILROY, G., ROBINSON, A., MOWETE, C., FURTADO, M., TUCKER, D., ATTWELL, L., MADDOX, J., SHENOUDA, A., SHAH, N., BOND, A., KELSEY, P., ABDULGAWAD, A., CLAY, J., LANGRIDGE, A., TURNER, D., PARRY, H., BUKA, R., PRYCE, A., ARASARETNAM, A., WILLAN, J., WILLOUGHBY, S., WALKER, R., CAMPBELL, G., PHILLIPS, N., MCCARTHY, H., JOHNSTON, R., LAMBERT, J., OSBORNE, W., MCKAY, P., LEWIS, D., BISHTON, M. and CROSBIE, N., 2020. Ibrutinib at first relapse for mantle cell lymphoma: a United Kingdom real world analysis of outcomes in 185 Patients BRITISH JOURNAL OF HAEMATOLOGY. 189, 104-105
MARTINEZ-CALLE, N., KIRKWOOD, A. A., LAMB, M., SMITH, A., MANOS, K., SHRUBSOLE, C., GRAY, N., LADANI, S., LEWIS, K., BISHTON, M., AHEARNE, M., HAWKES, E., OSBORNE, W., COLINS, G., BURTON, C. and FOX, C. P., 2020. An international multicentre study of consecutively diagnosed patients with ALCL: outcomes following first-line therapy in routine clinical practice BRITISH JOURNAL OF HAEMATOLOGY. 189, 103-104
BISHTON, MARK J., RULE, SIMON, WILSON, WILLIAM, TURNER, DEBORAH, PATMORE, RUSSELL, CLIFTON-HADLEY, LAURA, MCMILLAN, ANDREW, LUSH, RICHARD and HAYNES, ANDREW, 2020. The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD)versusfludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival BRITISH JOURNAL OF HAEMATOLOGY. 190(4), 545-554
GONZALEZ-BARCA, E., BOUMENDIL, A., BLAISE, D., TRNENY, M., MASSZI, T., FINEL, H., MICHIELI, M. G., BITTENBRING, J. T., GRITTI, G., SNOWDEN, J. A., BISHTON, M., BRUNO, B., GONZALEZ DE VILLAMBROSIA, S., JANIKOVA, A., LELEU, X., ANAGNOSTOPOULOS, A., POIRE, X., CRYSANDT, M., OZKURT, Z. N., VANDENBERGHE, E., ITALA-REMES, M., CAHN, J. Y., JANTUNEN, E., SCHROYENS, W., MAERTENS, J., ESQUIROL, A., DREGER, P., MONTOTO, S. and SUREDA, A., 2020. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) BONE MARROW TRANSPLANTATION. 55(2), 393-399
MARTINEZ-CALLE, NICOLAS, KIRKWOOD, AMY A., LAMB, MAXINE, SMITH, ALEXANDRA, MANOS, KATE, SHRUBSOLE, CAROLINE, GRAY, NICOLA, LADANI, SAPNA, LEWIS, KATHARINE LOUISE, BISHTON, MARK, AHEARNE, MATTHEW J., HAWKES, ELIZA A., OSBORNE, WENDY, COLLINS, GRAHAM P., BURTON, CATHY and FOX, CHRISTOPHER P., 2019. An International Multicentre Study of Consecutively Diagnosed Patients wSith ALCL: Outcomes Following First-Line Therapy in Routine Clinical Practice BLOOD. 134,
BISHTON, MARK, ZINZANI, PIER LUIGI, MARSHALL, SCOTT, CONTEH, VERONICA, RODRIGUEZ FERNANDEZ, ALICIA, KIM, SOOKYOUNG and LEE, YOUNG NAM, 2019. Rapid Infusion with CT-P10 in Patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Six Month Follow-up from a European Non-Interventional Post-Authorisation Safety Study BLOOD. 134,
MCCULLOCH, RORY, RULE, SIMON, EYRE, TOBY A., GORADIA, HARSHITA, BOLAM, SIMON, CREASEY, THOMAS, TUCKER, DAVID, FURTADO, MICHELLE, MILES, OLIVER, HARRISON, SAMUEL, SHENOUDA, AMIR, ROBINSON, ANDREW, WILSON, MATTHEW, MCMILLAN, ANNABEL, SHAH, NIMISH, MCILROY, GRAHAM, DUTTON, DAVID, BOND, ADAM, ATTWELL, LUKE, LANGRIDGE, ALEXANDER, PARRY, HELEN, WILLAN, JOHN, CAMPBELL, GAVIN, TURNER, DEBORAH, LEWIS, DAVID, MCCARTHY, HELEN, LAMBERT, JONATHAN, MCKAY, PAMELA, PHILLIPS, NEIL, PANEESHA, SHANKARA, OSBORNE, WENDY, BISHTON, MARK and CROSBIE, NICOLA, 2019. Ibrutinib at First Relapse for Mantle Cell Lymphoma: A United Kingdom Real World Analysis of Outcomes in 169 Patients BLOOD. 134,
EYRE, TOBY A., MARTINEZ-CALLE, NICOLAS, HILDYARD, CATHERINE, EYRE, DAVID W., PLASCHKES, HANNAH, GRIFFITH, JOHN, WOLF, JULIA, FIELDS, PAUL A., GUNAWAN, ARIEF, OLIVER, REBECCA, BOOTH, STEPHEN, MCMILLAN, ANDREW, FOX, CHRISTOPHER P., BISHTON, MARK, COLLINS, GRAHAM P. and HATTON, CHRIS S. R., 2019. Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP BRITISH JOURNAL OF HAEMATOLOGY. 186(4), E94-E98
WILSON, MATTHEW R., BAGGULEY, TIMOTHY, SMITH, ALEXANDRA, ROMAN, EVE, PATMORE, RUSSELL, HANLON, KATHARINE, LEACH, MIKE, BISHTON, MARK, BURTON, CATHY and MCKAY, PAM, 2019. Frontline management of nodular lymphocyte predominant Hodgkin lymphoma - a retrospective UK multicentre study BRITISH JOURNAL OF HAEMATOLOGY. 186(6), E214-E217
BARRACLOUGH, ALLISON, ALZAHRANI, MUSA, ETTRUP, MARIANNE SCHMIDT, BISHTON, MARK, VAN VLIET, CHRIS, FARINHA, PEDRO, GOULD, CLARE, BIRCH, SIMONE, SEHN, LAURIE H., SOVANI, VISHAKHA, WARD, MITCHELL STEVEN, AUGUSTSON, BRADLEY, BICCLER, JORNE, CONNORS, JOSEPH M., SCOTT, DAVID W., GANDHI, MAHER K., SAVAGE, KERRY J., EL-GALALY, TAREC, VILLA, DIEGO and CHEAH, CHAN YOON, 2019. COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study BLOOD ADVANCES. 3(13), 2013-2021
EYRE, TOBY A., KIRKWOOD, AMY A., WOLF, JULIA, HILDYARD, CATHERINE, MERCER, CAROLYN, PLASCHKES, HANNAH, GRIFFITH, JOHN, FIELDS, PAUL, GUNAWAN, ARIEF, OLIVER, REBECCA, BOOTH, STEPHEN, MARTINEZ-CALLE, NICOLAS, MCMILLAN, ANDREW, BISHTON, MARK, FOX, CHRISTOPHER P., COLLINS, GRAHAM P. and HATTON, CHRIS S. R., 2019. Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity BRITISH JOURNAL OF HAEMATOLOGY. 187(2), 185-194
WEBB, NICHOLAS J. A., WOOLLEY, REBECCA L., LAMBE, TOSIN, FREW, EMMA, BRETTELL, ELIZABETH A., BARSOUM, EMMA N., TROMPETER, RICHARD S., CUMMINS, CAROLE, DEEKS, JONATHAN J., WHEATLEY, KEITH and IVES, NATALIE J., 2019. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation BMJ-BRITISH MEDICAL JOURNAL. 365,
MANSOUR, MARIAM, HAUPT, SUE, CHAN, AI-LEEN, GODDE, NATHAN, RIZZITELLI, ALEXANDRA, LOI, SHERENE, CARAMIA, FRANCO, DEB, SIDDHARTHA, TAKANO, ELENA A., BISHTON, MARK, JOHNSTONE, CAMERON, MONAHAN, BRENDON, LEVAV-COHEN, YARRA, JIANG, YONG-HUI, YAP, ALPHA S., FOX, STEPHEN, BERNARD, ORA, ANDERSON, ROBIN and HAUPT, YGAL, 2019. The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling (Retraction of Vol 76, Pg 4236, 2016) CANCER RESEARCH. 79(11), 3008-3008
NG, ZI YUN, BISHTON, MARK, RITCHIE, DAVID, CAMPBELL, ROBERT, GILBERTSON, MICHAEL, HILL, KATE, RATNASINGAM, SUMITA, SCHWARER, ANTHONY, MANOS, KATE, SHORTEN, SOPHIE, NG, MELISSA, NELSON, NILES, XIN, LIU, DE MEL WIDANALAGE, SANJAY, SUNNY, TENNY, PURTILL, DUNCAN, POON, MICHELLE, JOHNSTON, ANNA, COCHRANE, TARA, LEE, HUI-PENG, HAPGOOD, GREG, TAM, CONSTANTINE, OPAT, STEPHEN, HAWKES, ELIZA, SEYMOUR, JOHN and CHEAH, CHAN YOON, 2019. A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma HEMATOLOGICAL ONCOLOGY. 37(3), 253-260
SORIGUE, MARC, BISHTON, MARK, DOMINGO-DOMENECH, EVA, MCMILLAN, ANDREW, PRUSILA, ROOSA, GARCIA, OLGA, KUUSISTO, MILLA, CONDOM, MARIA, TAPIA, GUSTAVO, RIBERA, JOSEP-MARIA, KUITTINEN, OUTI, FOX, CHRISTOPHER P. and SANCHO, JUAN-MANUEL, 2019. Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma LEUKEMIA & LYMPHOMA. 60(10), 2524-2531
MARTINEZ-CALLE, NICOLAS, HARTLEY, SARAH, AHEARNE, MATTHEW, KASENDA, BENJAMIN, BEECH, AMY, KNIGHT, HELEN, BALOTIS, CONSTANTINE, KENNEDY, BEN, WAGNER, SIMON, DYER, MARTIN J. S., SMITH, DEAN, MCMILLAN, ANDREW K., MIALL, FIONA, BISHTON, MARK and FOX, CHRISTOPHER P., 2019. Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis BRITISH JOURNAL OF HAEMATOLOGY. 184(6), 957-968
EYRE, T. A., MARTINEZ-CALLE, N., HILDYARD, C., EYRE, D. W., PLASCHKES, H., GRIFFITH, J., WOLF, J., FIELDS, P., GUNAWAN, A., OLIVER, R., DJEBBARI, F., BOOTH, S., MCMILLAN, A., FOX, C. P., BISHTON, M. J., COLLINS, G. P. and HATTON, C. S. R., 2019. Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age JOURNAL OF INTERNAL MEDICINE. 285(6), 681-692
BISHTON, MARK J., LONG, HEATHER M., DOWELL, ALEXANDER C., MECKIFF, BENJAMIN J., BYRNE, CATHERINE and FOX, CHRISTOPHER P., 2019. Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery LEUKEMIA & LYMPHOMA. 60(8), 2075-2078
EYRE, TOBY A., MARTINEZ-CALLE, NICOLAS, KIRKWOOD, AMY A., HILDYARD, CATHERINE, KESAVAN, MURALI, BUTLER, JOSEPH, MERCER, CAROLYN, DJEBBARI, FAOUZI, PLASCHKES, HANNAH, GRIFFITH, JOHN, BOOTH, STEPHEN, MCMILLAN, ANDREW, BISHTON, MARK, FOX, CHRISTOPHER P., COLLINS, GRAHAM P. and HATTON, CHRIS, 2018. CNS Relapse Risk in Consecutive R-CHOP/R-Mini-CHOP-Treated Elderly DLBCL Is Low, with High Risk Particularly Apparent in Those with CNS IPI 5-6 and/or Renal/Adrenal Involvement BLOOD. 132,
EYRE, TOBY A., MARTINEZ-CALLE, NICOLAS, HILDYARD, CATHERINE, EYRE, DAVID W., PLASCHKES, HANNAH, GRIFFITH, JONATHAN, WOLF, JULIA, FOX, CHRIS P., MCMILLAN, ANDREW, BISHTON, MARK, COLLINS, GRAHAM P. and HATTON, CHRIS, 2018. Impact of Intended and Relative Dose Intensity of RCHOP in a Large, Consecutive Cohort of Elderly DLBCL Patients: No Difference in DFS for 70-80 Years Versus > 80 Years and Idi Independently Predicts Survival BLOOD. 132,
BALENDRA, JOHN R., GLOVER, ALEXANDER, XIN, LIU, DE MEL, SANJAY, JEYASEKHARAN, ANAND, JONES, STEPHEN G., BISHTON, MARK and CHEAH, CHAN Y., 2018. Impact of Induction Chemotherapy and Primary CNS Prophylaxis on Outcomes in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrange ments (HGBL-DH/TH) or HGBL-NOS: An International Multi-Center Retrospective Analysis BLOOD. 132,
JOSHI, KOMAL, HUBBARD, RICHARD and BISHTON, MARK J., 2018. Population-based study of mantle cell lymphoma: Improvements in survival only seen in younger patients HEMATOLOGICAL ONCOLOGY. 36(3), 604-606
GLOVER, A., FOX, C., MCMILLAN, A., BEECH, A., MARTINEZ-CALLE, N., GRIFFITHS, C., RICHARDSON, F., RUSSEL, N. and BISHTON, M., 2018. Autologous transplantation using BendaEAM conditioning; a single centre experience and comparison with a historical matched cohort using BEAM conditioning BRITISH JOURNAL OF HAEMATOLOGY. 181, 26-26
MARTINEZ-CALLE, N., BEECH, A., SOVANI, V., PAINE, S., AUER, D., SMITH, S., BISHTON, M. and FOX, C., 2018. Analysis of consecutive PCNSL patients from a regional UK Neurosciences centre; survival in an older cohort compares favourably to trial outcomes in younger patients BRITISH JOURNAL OF HAEMATOLOGY. 181, 82-83
LAMBE, TOSIN, FREW, EMMA, IVES, NATALIE J., WOOLLEY, REBECCA L., CUMMINS, CAROLE, BRETTELL, ELIZABETH A., BARSOUM, EMMA N. and WEBB, NICHOLAS J. A., 2018. Mapping the Paediatric Quality of Life Inventory (PedsQL (TM)) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children PHARMACOECONOMICS. 36(4), 451-465
SORIGUE, M., BISHTON, M., MC MILLAN, A., PRUSILA, R., GARCIA, O., KUUSISTO, M., TAPIA, G., MORENO, M., NAVARRO, J. T., RIBERA, J. M., KUITINEN, O., FOX, C. and SANCHO, J. M., 2017. REFRACTARITY TO IMMUNOTHERAPY OR IMMUNOCHIMIOTERAPY IN LYMPHOMA OF THE MARGINAL ZONE HAEMATOLOGICA. 102, 226-227
GONZALEZ-BARCA, EVA, BOUMENDIL, ARIANE, BLAISE, DIDIER, TRNENY, MAREK, MASSZI, TAMAS, FINEL, HERVE, MICHIELI, MARIAGRAZIA, BITTENBRING, JORG THOMAS, GRITTI, GIUSEPPE, SNOWDEN, JOHN A., BISHTON, MARK, BRUNO, BENEDETTO, DE VILLAMBROSIA, SONIA GONZALEZ, JANIKOVA, ANDREA, LELEU, XAVIER, ANAGNOSTOPOULOS, ACHILLES, POIRE, XAVIER, CRYSANDT, MARTINA, OZKURT, ZUBEYDE NUR, VANDENBERGHE, ELISABETH, ITALA-REMES, MAIJA, CAHN, JEAN-YVES, JANTUNEN, ESA, SCHROYENS, WILFRIED, MAERTENS, JOHAN, ESQUIROL, ALBERT, DREGER, PETER, MONTOTO, SILVIA and SUREDA, ANNA, 2017. Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT) BLOOD. 130,
BARRACLOUGH, ALLISON, ALZAHRANI, MUSA, ETTRUP, MARIANNE SCHMIDT, BISHTON, MARK, VAN VLIET, CHRIS, SEHN, LAURIE H., SOVANI, VISHAKHA, WARD, MITCHELL STEVEN, AUGUSTSON, BRADLEY, FARINHA, PEDRO, BICCLER, JORNE LIONEL, CONNORS, JOSEPH M., SCOTT, DAVID W., SAVAGE, KERRY J., EL-GALALY, TAREC CHRISTOFFER, VILLA, DIEGO and CHEAH, CHAN YOON, 2017. Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP +/- Radiotherapy: An International Multi-Center Retrospective Study BLOOD. 130,
MCMILLAN, ANDREW K., HARTLEY, SARAH, LOUGHRAN, CATHERINE, BISHTON, MARK, JAMES, ELEANOR, GRIFFITHS, CATHERINE, RICHARDSON, FAITH and FOX, CHRISTOPHER P., 2017. Successful Salvage of Refractory Burkitts Lymphoma Using Maximum Intensity of the DA EPOCH-R Regimen-a Case Report BLOOD. 130,
NG, ZI YUN, BISHTON, MARK, RITCHIE, DAVID, CAMPBELL, ROBERT, GILBERTSON, MICHAEL P., HILL, KATE, RATNASINGAM, SUMITA, SCHWARER, ANTHONY P., MANOS, KATE, SHORTEN, SOPHIE, NG, MELISSA LIET HING, NELSON, NILES ELIZABETH, XIN, LIU, DE MEL, SANJAY, SUNNY, TENNY, PURTILL, DUNCAN, POON, MICHELLE, JOHNSTON, ANNA M., COCHRANE, TARA, LEE, HUI-PENG, HAPGOOD, GREG, TAM, CONSTANTINE S., OPAT, STEPHEN, HAWKES, ELIZA A., SEYMOUR, JOHN F. and CHEAH, CHAN YOON, 2017. An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma BLOOD. 130,
BISHTON, M. J., LEAHY, M. F., HICKS, R. J., TURNER, J. H., MCQUILLAN, A. D. and SEYMOUR, J. F., 2008. Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab ANNALS OF ONCOLOGY. 19(9), 1629-1633
RASHEED, WALID, BISHTON, MARK, JOHNSTONE, RICKY W. and PRINCE, H. MILES, 2008. Histone deacetylase inhibitors in lymphoma and solid malignancies EXPERT REVIEW OF ANTICANCER THERAPY. 8(3), 413-432
BISHTON, MARK J., HICKS, RODNEY J., WESTERMAN, DAVID A., PRINCE, MILES H., WOLF, MAX and SEYMOUR, JOHN F., 2008. A prospective study of the separate predictive capabilities of (18)[F]-FDG-PET and molecular response in patients with relapsed indolent nonHodgkin's lymphoma following treatment with iodine-(131)-rituximab radio-immunotherapy HAEMATOLOGICA. 93(5), 789-790
FOX, C. P., MCMILLAN, A. K., BISHTON, M. J., HAYNES, A. P. and RUSSELL, N. H., 2008. IVE is a more effective stem cell mobilisation regimen than ICE in the context of salvage therapy for lymphoma BRITISH JOURNAL OF HAEMATOLOGY. 141, 51-51
PRINCE, H. M., QUACH, H., YUEN, K., KEEGAN, M., COPEMAN, M., PEINERT, S., BISHTON, M., WOLF, M., WESTERMAN, D., RITCHIE, D., SEYMOUR, J. F., CARNEY, D. and HARRISON, S. J., 2008. Safety and efficacy of the combination of bortezomib and dexamethasone with the deacetylase inhibitor romidepsin in patients with relapsed and refractory multiple myeloma: preliminary results of a phase I trial BRITISH JOURNAL OF HAEMATOLOGY. 141, 33-33
PRINCE, H. MILES, BISHTON, MARK and HARRISON, SIMON, 2008. The potential of histone deacetylase inhibitors for the treatment of multiple myeloma LEUKEMIA & LYMPHOMA. 49(3), 385-387
BISHTON, MARK J., HICKS, ROD, WESTERMAN, DAVID ALAN, PRINCE, MILES, WOLF, MAX and SEYMOUR, JOHN FRANCIS, 2007. A prospective study of the prognostic impact of (18)[F]-FDG-PET and molecular response in patients with relapsed indolent non-hodgkin lymphoma (NHL) following iodine-131-rituximab radio-immunotherapy (RIT) BLOOD. 110(11), 1002A-1002A
BISHTON, MARK J., LEAHY, MICHAEL F., HICKS, ROD J., TURNER, J. HARVEY, MCQUILLAN, AD and SEYMOUR, JOHN FRANCIS, 2007. Repeat treatment with iodine-131-pituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin lymphoma (NHL) who had previously responded to this therapy BLOOD. 110(11), 1000A-1000A
PRINCE, MILES, QUACH, HANG, NEESON, PAUL, KEEGAN, MITCH, COPEMAN, MICHAEL, PEINERT, STEFAN, BISHTON, MARK, WOLF, MAX, RITCHIE, DAVID, SEYMOUR, JOHN F., CARNEY, DENNIS, WESTERMAN, DAVID and HARRISON, SIMON, 2007. Safety and efficacy of the combination of bortezomib with the deacetylase inhibitor romidepsin in patients with relapsed or refractary multiple myeloma: Preliminary results of a phase I trial BLOOD. 110(11), 353A-354A
BISHTON, MARK, KENEALY, MELITA, JOHNSTONE, RICKY, RASHEED, WALID and PRINCE, H. MILES, 2007. Epigenetic targets in hematological malignancies: Combination therapies with HDACis and demethylating agents EXPERT REVIEW OF ANTICANCER THERAPY. 7(10), 1439-1449
LIEW, M. S., BISHTON, M. J., JANUSZEWICZ, H., ALATAKIS, S. and PRINCE, H. M., 2007. Spinal epidural lipomatosis in myeloma LEUKEMIA & LYMPHOMA. 48(10), 2068-2070